GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Shiller PE Ratio

Lattice Biologics (TSXV:LBL.H) Shiller PE Ratio : (As of Jun. 11, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lattice Biologics Shiller PE Ratio Historical Data

The historical data trend for Lattice Biologics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Shiller PE Ratio Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lattice Biologics's Shiller PE Ratio

For the Medical Devices subindustry, Lattice Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lattice Biologics's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Shiller PE Ratio falls into.



Lattice Biologics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lattice Biologics's E10 for the quarter that ended in Jun. 2021 is calculated as:

For example, Lattice Biologics's adjusted earnings per share data for the three months ended in Jun. 2021 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2021 (Change)*Current CPI (Jun. 2021)
=-0/114.6314*114.6314
=0.000

Current CPI (Jun. 2021) = 114.6314.

Lattice Biologics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201109 6.376 95.727 7.635
201112 -20.343 95.213 -24.492
201203 0.000 96.783 0.000
201206 -0.048 96.819 -0.057
201209 -0.034 97.633 -0.040
201212 -0.179 96.871 -0.212
201303 0.000 98.209 0.000
201306 -0.020 98.518 -0.023
201309 -0.024 98.790 -0.028
201312 -0.174 98.326 -0.203
201403 -0.226 99.695 -0.260
201406 -0.017 100.560 -0.019
201409 -0.018 100.428 -0.021
201412 -0.252 99.070 -0.292
201503 -0.023 99.621 -0.026
201506 -0.009 100.684 -0.010
201509 -0.065 100.392 -0.074
201512 -0.453 99.792 -0.520
201603 -0.026 100.470 -0.030
201606 -0.052 101.688 -0.059
201609 -0.026 101.861 -0.029
201612 -0.027 101.863 -0.030
201703 -0.013 102.862 -0.014
201706 0.027 103.349 0.030
201709 -0.012 104.136 -0.013
201712 -0.002 104.011 -0.002
201803 -0.003 105.290 -0.003
201806 -0.013 106.317 -0.014
201809 0.000 106.507 0.000
201812 -0.002 105.998 -0.002
201903 0.001 107.251 0.001
201906 -0.004 108.070 -0.004
201909 -0.009 108.329 -0.010
201912 -0.001 108.420 -0.001
202003 -0.014 108.902 -0.015
202006 -0.004 108.767 -0.004
202009 0.000 109.815 0.000
202012 -0.003 109.897 -0.003
202103 -0.004 111.754 -0.004
202106 0.000 114.631 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lattice Biologics  (TSXV:LBL.H) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lattice Biologics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lattice Biologics (TSXV:LBL.H) Business Description

Traded in Other Exchanges
N/A
Address
512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines